Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ensysce Biosciences (ENSC) Interest Expenses (2020 - 2025)

Ensysce Biosciences (ENSC) has disclosed Interest Expenses for 6 consecutive years, with $6369.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Expenses rose 56.76% to $6369.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $24138.0, a 98.51% decrease, with the full-year FY2024 number at $1.3 million, up 264.59% from a year prior.
  • Interest Expenses was $6369.0 for Q3 2025 at Ensysce Biosciences, up from $3160.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.2 million in Q1 2024 to a low of -$47753.0 in Q4 2022.
  • A 5-year average of $166510.3 and a median of $9201.0 in 2023 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: tumbled 148.99% in 2022, then soared 83271.08% in 2024.
  • Ensysce Biosciences' Interest Expenses stood at $97481.0 in 2021, then crashed by 148.99% to -$47753.0 in 2022, then surged by 822.05% to $344799.0 in 2023, then plummeted by 96.88% to $10753.0 in 2024, then tumbled by 40.77% to $6369.0 in 2025.
  • Per Business Quant, the three most recent readings for ENSC's Interest Expenses are $6369.0 (Q3 2025), $3160.0 (Q2 2025), and $3856.0 (Q1 2025).